Stocks
Sanofi (SNY) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, € | ? | 10 762 000 000 | 12 563 000 000 | 14 062 000 000 | 15 542 000 000 | 12 959 000 000 | 15 807 000 000 | ||
| Changes by years, y/y, % | -9% | +17% | +12% | +11% | -17% | +3.0% | |||
Sanofi. EBITDA US GAAP, €
Sanofi. EBITDA US GAAP, changes, %
Sanofi. EBITDA US GAAP, sum by quarters, €
Sanofi (SNY) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, € | ? | 2 833 000 000 | 2 833 000 000 | 4 160 000 000 | 5 949 000 000 | 2 865 000 000 | 15 807 000 000 | |
| Changes by years, y/y, % | +7% | +7% | -22% | +100% | -20% | |||
| Changes by quarters, q/q, % | -21% | 0% | +47% | +43% | -52% | |||
